FORWARD GLOBAL

Lobbying for ELECTRX · Pharmacy benefits strategy

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Ohio · House · Senate · $50,000.00 income · posted Apr 24, 2026

Lobbying activity 1

Health Issues

Policy and regulatory topics relating to section 804 of the FD&C Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem